OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 7.22
-0.07 (-0.96%)
Jul 3, 2026, 5:17 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 101.43 million as of July 2, 2026. Its market cap has increased by 41.03% in one year.
Market Cap
101.43M
Enterprise Value
107.99M
Revenue
71.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.22
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 101.43M, an increase of 13.94%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 101.43M | 18.64% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 132.01M |
| NextCell Pharma AB | 114.39M |
| Alligator Bioscience AB | 106.78M |
| IRLAB Therapeutics AB | 105.49M |
| Biovica International AB | 103.92M |
| Spago Nanomedical AB | 92.61M |
| Scandinavian ChemoTech AB | 92.40M |
| Annexin Pharmaceuticals AB | 85.06M |